These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 27490498)

  • 21. Accelerated structure-based design of chemically diverse allosteric modulators of a muscarinic G protein-coupled receptor.
    Miao Y; Goldfeld DA; Moo EV; Sexton PM; Christopoulos A; McCammon JA; Valant C
    Proc Natl Acad Sci U S A; 2016 Sep; 113(38):E5675-84. PubMed ID: 27601651
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subtype selectivity of the positive allosteric action of alcuronium at cloned M1-M5 muscarinic acetylcholine receptors.
    Jakubík J; Bacáková L; el-Fakahany EE; Tucek S
    J Pharmacol Exp Ther; 1995 Sep; 274(3):1077-83. PubMed ID: 7562472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a radioligand, [(3)H]LY2119620, to probe the human M(2) and M(4) muscarinic receptor allosteric binding sites.
    Schober DA; Croy CH; Xiao H; Christopoulos A; Felder CC
    Mol Pharmacol; 2014 Jul; 86(1):116-23. PubMed ID: 24807966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Toward an understanding of the structural basis of allostery in muscarinic acetylcholine receptors.
    Burger WAC; Sexton PM; Christopoulos A; Thal DM
    J Gen Physiol; 2018 Oct; 150(10):1360-1372. PubMed ID: 30190312
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allosteric modulation of muscarinic acetylcholine receptors.
    Tucek S; Proska J
    Trends Pharmacol Sci; 1995 Jun; 16(6):205-12. PubMed ID: 7652930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New insight into active muscarinic receptors with the novel radioagonist [³H]iperoxo.
    Schrage R; Holze J; Klöckner J; Balkow A; Klause AS; Schmitz AL; De Amici M; Kostenis E; Tränkle C; Holzgrabe U; Mohr K
    Biochem Pharmacol; 2014 Aug; 90(3):307-19. PubMed ID: 24863257
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allosteric binding sites on muscarinic acetylcholine receptors.
    Wess J
    Mol Pharmacol; 2005 Dec; 68(6):1506-9. PubMed ID: 16183853
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-function studies of muscarinic acetylcholine receptors.
    Leach K; Simms J; Sexton PM; Christopoulos A
    Handb Exp Pharmacol; 2012; (208):29-48. PubMed ID: 22222693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radiolabeled Dibenzodiazepinone-Type Antagonists Give Evidence of Dualsteric Binding at the M
    Pegoli A; She X; Wifling D; Hübner H; Bernhardt G; Gmeiner P; Keller M
    J Med Chem; 2017 Apr; 60(8):3314-3334. PubMed ID: 28388054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Allosteric activators of muscarinic receptors as novel approaches for treatment of CNS disorders.
    Digby GJ; Shirey JK; Conn PJ
    Mol Biosyst; 2010 Aug; 6(8):1345-54. PubMed ID: 20582339
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation and allosteric modulation of a muscarinic acetylcholine receptor.
    Kruse AC; Ring AM; Manglik A; Hu J; Hu K; Eitel K; Hübner H; Pardon E; Valant C; Sexton PM; Christopoulos A; Felder CC; Gmeiner P; Steyaert J; Weis WI; Garcia KC; Wess J; Kobilka BK
    Nature; 2013 Dec; 504(7478):101-6. PubMed ID: 24256733
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cryptic pocket formation underlies allosteric modulator selectivity at muscarinic GPCRs.
    Hollingsworth SA; Kelly B; Valant C; Michaelis JA; Mastromihalis O; Thompson G; Venkatakrishnan AJ; Hertig S; Scammells PJ; Sexton PM; Felder CC; Christopoulos A; Dror RO
    Nat Commun; 2019 Jul; 10(1):3289. PubMed ID: 31337749
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacological hallmarks of allostery at the M4 muscarinic receptor elucidated through structure and dynamics.
    Vuckovic Z; Wang J; Pham V; Mobbs JI; Belousoff MJ; Bhattarai A; Burger WAC; Thompson G; Yeasmin M; Nawaratne V; Leach K; van der Westhuizen ET; Khajehali E; Liang YL; Glukhova A; Wootten D; Lindsley CW; Tobin A; Sexton P; Danev R; Valant C; Miao Y; Christopoulos A; Thal DM
    Elife; 2023 May; 12():. PubMed ID: 37248726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Probe dependence in the allosteric modulation of a G protein-coupled receptor: implications for detection and validation of allosteric ligand effects.
    Valant C; Felder CC; Sexton PM; Christopoulos A
    Mol Pharmacol; 2012 Jan; 81(1):41-52. PubMed ID: 21989256
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of 1,2,5-thiadiazoles as modulators of M₁/M₅ muscarinic receptor subtypes.
    Maheshwari A; Rao PS; Messer WS
    Bioorg Med Chem; 2014 Mar; 22(6):1838-44. PubMed ID: 24582400
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Application of a kinetic model to the apparently complex behavior of negative and positive allosteric modulators of muscarinic acetylcholine receptors.
    Avlani V; May LT; Sexton PM; Christopoulos A
    J Pharmacol Exp Ther; 2004 Mar; 308(3):1062-72. PubMed ID: 14711931
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Homology modeling of human muscarinic acetylcholine receptors.
    Thomas T; McLean KC; McRobb FM; Manallack DT; Chalmers DK; Yuriev E
    J Chem Inf Model; 2014 Jan; 54(1):243-53. PubMed ID: 24328076
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bitopic Ligands and Metastable Binding Sites: Opportunities for G Protein-Coupled Receptor (GPCR) Medicinal Chemistry.
    Fronik P; Gaiser BI; Sejer Pedersen D
    J Med Chem; 2017 May; 60(10):4126-4134. PubMed ID: 28140580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs.
    Dror RO; Green HF; Valant C; Borhani DW; Valcourt JR; Pan AC; Arlow DH; Canals M; Lane JR; Rahmani R; Baell JB; Sexton PM; Christopoulos A; Shaw DE
    Nature; 2013 Nov; 503(7475):295-9. PubMed ID: 24121438
    [TBL] [Abstract][Full Text] [Related]  

  • 40. M2 Subtype preferring dibenzodiazepinone-type muscarinic receptor ligands: Effect of chemical homo-dimerization on orthosteric (and allosteric?) binding.
    Keller M; Tränkle C; She X; Pegoli A; Bernhardt G; Buschauer A; Read RW
    Bioorg Med Chem; 2015 Jul; 23(14):3970-90. PubMed ID: 25650309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.